NVS
NOVARTIS AG
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 3/18/2026 | View on SEC |
| 424B5 | 3/17/2026 | View on SEC |
| FWP | 3/17/2026 | View on SEC |
| 424B5 | 3/16/2026 | View on SEC |
| 144 | 2/12/2026 | View on SEC |
| 144 | 2/9/2026 | View on SEC |
| S-8 | 2/4/2026 | View on SEC |
| 6-K | 2/4/2026 | View on SEC |
| 6-K | 2/4/2026 | View on SEC |
| IRANNOTICE | 2/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NVS |
| Company Name | NOVARTIS AG |
| CIK | 1114448 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | V8 |
| Phone | 01141613241111 |